Firefly Neuroscience, Inc. - SIC # 7370 -

Ticker Exchange SIC # Website Latest Ticker
AIFF Nasdaq 7370 fireflyneuro.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Firefly Neuroscience, Inc.

Firefly Neuroscience Advances AI-Driven BNA™ Technology in Neuroscience Drug Development after Completing Successful Research Collaborations with Takeda and Novartis - Sep 20th, 2024 1:00 pm
Firefly Neuroscience Announces Partnership with Zeto to Integrate and Distribute its BNA™ Technology with Zeto's FDA-Cleared EEG Device Platform - Sep 10th, 2024 1:00 pm
Firefly Neuroscience Appoints Dr. Stella Vnook to its Board of Directors - Sep 5th, 2024 1:00 pm
Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwright’s 26th Annual Global Investment Conference September 9-11 - Aug 26th, 2024 1:00 pm
Firefly Neuroscience, an AI-Driven Brain Health Company, to Host Shareholder Update Call on September 4th - Aug 22nd, 2024 1:00 pm
Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management for Patients with Cognitive Disorders - Aug 21st, 2024 1:00 pm
UPDATE -- Firefly Neuroscience CEO Issues Letter to Stockholders Following Closing of Merger and Listing on Nasdaq - Aug 13th, 2024 8:06 pm
Firefly Neuroscience CEO Issues Letter to Stockholders Following Closing of Merger and Listing on Nasdaq - Aug 13th, 2024 1:00 pm